Trial Profile
A Pilot, Randomized, Double-blind, Placebo Controlled, Trial of Ramelteon for CPAP Non-Adherent Veterans With PTSD and Complex Insomnia
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms DORMI
- 08 Apr 2021 Status changed from discontinued to withdrawn prior to enrolment.
- 07 Oct 2020 According to clinicaltrials.gov, trial was discontinued due to lack of response.
- 02 Oct 2020 Status changed from recruiting to discontinued.